Filed: 8/14/2026ACC: 0002106181-26-000007
📋 What this filing means
KALEHUA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $139.53M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$139.53M
Total AUM (reported)
32.28M
Total Shares
Allocation by class
COM$55.66M39.9%
COM NEW$47.29M33.9%
COOMON STOCK$17.91M12.8%
SPONSORED ADS$11.60M8.3%
SHS$3.66M2.6%
CLASS A ORD$3.42M2.5%
Portfolio Concentration
Top 3$46.90M33.6%
4–10$56.20M40.3%
11–25$36.43M26.1%
Top 3 weight
33.6%
Top 10 weight
73.9%
Voting Authority Distribution
Total shares with voting rights: 32.28M
Sole
Full voting authority
32.28M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
Veradermics Inc
SOLEShares145.69K
TypeSH
Market value$17.91M
12.84%
Sole
145.69K
Shared
0.00
None
0.00
X4 Pharmaceuticals Inc
SOLEShares3.72M
TypeSH
Market value$17.39M
12.46%
Sole
3.72M
Shared
0.00
None
0.00
Compass Pathways Plc
SOLEShares819.69K
TypeSH
Market value$11.60M
8.31%
Sole
819.69K
Shared
0.00
None
0.00
Surrozen Inc
SOLEShares385.18K
TypeSH
Market value$10.00M
7.16%
Sole
385.18K
Shared
0.00
None
0.00
Aclaris Therapeutics Inc
SOLEShares1.83M
TypeSH
Market value$9.69M
6.95%
Sole
1.83M
Shared
0.00
None
0.00
Sionna Therapeutics Inc
SOLEShares197.07K
TypeSH
Market value$8.67M
6.21%
Sole
197.07K
Shared
0.00
None
0.00
Inhibikase Therapeutics Inc
SOLEShares3.82M
TypeSH
Market value$7.76M
5.56%
Sole
3.82M
Shared
0.00
None
0.00
Pharvaris NV
SOLEShares198.77K
TypeSH
Market value$6.87M
4.93%
Sole
198.77K
Shared
0.00
None
0.00
Karyopharm Therapeutics Inc
SOLEShares685.64K
TypeSH
Market value$6.70M
4.80%
Sole
685.64K
Shared
0.00
None
0.00
Septerna Inc
SOLEShares194.54K
TypeSH
Market value$6.52M
4.67%
Sole
194.54K
Shared
0.00
None
0.00
Inflarx Nv
SOLEShares2.90M
TypeSH
Market value$6.49M
4.65%
Sole
2.90M
Shared
0.00
None
0.00
Cyclerion Therapeutics Inc
SOLEShares1.65M
TypeSH
Market value$5.60M
4.01%
Sole
1.65M
Shared
0.00
None
0.00
Uniqure Nv
SOLEShares79.41K
TypeSH
Market value$3.66M
2.62%
Sole
79.41K
Shared
0.00
None
0.00
LeonaBio Inc
SOLEShares393.70K
TypeSH
Market value$3.62M
2.59%
Sole
393.70K
Shared
0.00
None
0.00
Damora Therapeutics Inc
SOLEShares139K
TypeSH
Market value$3.62M
2.59%
Sole
139K
Shared
0.00
None
0.00
MoonLake Immunotherapeutics
SOLEShares175.73K
TypeSH
Market value$3.42M
2.45%
Sole
175.73K
Shared
0.00
None
0.00
Tyra Biosciences Inc
SOLEShares74.47K
TypeSH
Market value$2.38M
1.70%
Sole
74.47K
Shared
0.00
None
0.00
Nuvectis Pharma Inc
SOLEShares100K
TypeSH
Market value$1.84M
1.32%
Sole
100K
Shared
0.00
None
0.00
Gossamer Bio Inc
SOLEShares11.15M
TypeSH
Market value$1.84M
1.32%
Sole
11.15M
Shared
0.00
None
0.00
Milestone Pharmaceuticals Inc
SOLEShares1.27M
TypeSH
Market value$1.70M
1.22%
Sole
1.27M
Shared
0.00
None
0.00
Atyr Pharma Inc
SOLEShares1.79M
TypeSH
Market value$1.07M
0.76%
Sole
1.79M
Shared
0.00
None
0.00
Instil Bio Inc
SOLEShares99.60K
TypeSH
Market value$765.9K
0.55%
Sole
99.60K
Shared
0.00
None
0.00
Tscan Therapeutics Inc
SOLEShares454.88K
TypeSH
Market value$445.8K
0.32%
Sole
454.88K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Veradermics IncSOLE | COOMON STOCK | 145.69K | SH | $17.91M 12.84% | 145.69K | 0.00 | 0.00 |
X4 Pharmaceuticals IncSOLE | COM NEW | 3.72M | SH | $17.39M 12.46% | 3.72M | 0.00 | 0.00 |
Compass Pathways PlcSOLE | SPONSORED ADS | 819.69K | SH | $11.60M 8.31% | 819.69K | 0.00 | 0.00 |
Surrozen IncSOLE | COM NEW | 385.18K | SH | $10.00M 7.16% | 385.18K | 0.00 | 0.00 |
Aclaris Therapeutics IncSOLE | COM | 1.83M | SH | $9.69M 6.95% | 1.83M | 0.00 | 0.00 |
Sionna Therapeutics IncSOLE | COM | 197.07K | SH | $8.67M 6.21% | 197.07K | 0.00 | 0.00 |
Inhibikase Therapeutics IncSOLE | COM NEW | 3.82M | SH | $7.76M 5.56% | 3.82M | 0.00 | 0.00 |
Pharvaris NVSOLE | COM | 198.77K | SH | $6.87M 4.93% | 198.77K | 0.00 | 0.00 |
Karyopharm Therapeutics IncSOLE | COM NEW | 685.64K | SH | $6.70M 4.80% | 685.64K | 0.00 | 0.00 |
Septerna IncSOLE | COM | 194.54K | SH | $6.52M 4.67% | 194.54K | 0.00 | 0.00 |
Inflarx NvSOLE | COM | 2.90M | SH | $6.49M 4.65% | 2.90M | 0.00 | 0.00 |
Cyclerion Therapeutics IncSOLE | COM | 1.65M | SH | $5.60M 4.01% | 1.65M | 0.00 | 0.00 |
Uniqure NvSOLE | SHS | 79.41K | SH | $3.66M 2.62% | 79.41K | 0.00 | 0.00 |
LeonaBio IncSOLE | COM | 393.70K | SH | $3.62M 2.59% | 393.70K | 0.00 | 0.00 |
Damora Therapeutics IncSOLE | COM NEW | 139K | SH | $3.62M 2.59% | 139K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | CLASS A ORD | 175.73K | SH | $3.42M 2.45% | 175.73K | 0.00 | 0.00 |
Tyra Biosciences IncSOLE | COM | 74.47K | SH | $2.38M 1.70% | 74.47K | 0.00 | 0.00 |
Nuvectis Pharma IncSOLE | COM | 100K | SH | $1.84M 1.32% | 100K | 0.00 | 0.00 |
Gossamer Bio IncSOLE | COM | 11.15M | SH | $1.84M 1.32% | 11.15M | 0.00 | 0.00 |
Milestone Pharmaceuticals IncSOLE | COM | 1.27M | SH | $1.70M 1.22% | 1.27M | 0.00 | 0.00 |
Atyr Pharma IncSOLE | COM NEW | 1.79M | SH | $1.07M 0.76% | 1.79M | 0.00 | 0.00 |
Instil Bio IncSOLE | COM NEW | 99.60K | SH | $765.9K 0.55% | 99.60K | 0.00 | 0.00 |
Tscan Therapeutics IncSOLE | COM | 454.88K | SH | $445.8K 0.32% | 454.88K | 0.00 | 0.00 |